Cite
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
MLA
Nölting, Svenja, et al. “Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.” PloS One, vol. 10, no. 12, Dec. 2015, p. e0143830. EBSCOhost, https://doi.org/10.1371/journal.pone.0143830.
APA
Nölting, S., Maurer, J., Spöttl, G., Aristizabal Prada, E. T., Reuther, C., Young, K., Korbonits, M., Göke, B., Grossman, A., & Auernhammer, C. J. (2015). Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways. PloS One, 10(12), e0143830. https://doi.org/10.1371/journal.pone.0143830
Chicago
Nölting, Svenja, Julian Maurer, Gerald Spöttl, Elke Tatjana Aristizabal Prada, Clemens Reuther, Karen Young, Márta Korbonits, Burkhard Göke, Ashley Grossman, and Christoph J Auernhammer. 2015. “Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.” PloS One 10 (12): e0143830. doi:10.1371/journal.pone.0143830.